Protak Scientific invest in new premises

Published: 23-May-2018
Estates & Facilities Pharmaceutical

Protak Scientific will shortly be moving to brand new offices in Merstham, Surrey


Protak Scientific announced that it will be shortly moving to brand new offices in Merstham, Surrey.

Investing more than a million pounds is never an easy decision, said the company. However, it is the natural progression to support its growing multinational pharmaceutical customer base.

Phillip Godden, CEO of Protak Scientific said: “To support our worldwide growth we have obtained new offices in Merstham Surrey, the offices are currently undergoing a refurbishment programme, which will see the installation of a graded and qualified GMP facility for long-term production."

“We are investing in our success so far with a facility that will support our long-term growth and that of our distributors worldwide."

  • Companies:
  • Protak Scientific
See more

You may also like

Analysis

Phillip Godden speaks up about Enzyme Indicator technology

Read more
What is the market penetration of the EI technology and why should companies consider the new method for bio-decontamination validation? Phillip Godden, Protak Scientific CEO, answers these questions and comments on the support received by the MHRA

Trending Articles

  1. Syntegon launches new "Settle Plate Changer" for automated viable monitoring Syntegon has patented its new Settle Plate Changer (SPC) for automated viable monitoring in the aseptic filling process
  2. APIs: Bioreactor hoists with a multipurpose twist Peter Devenny of PalPharma describes the solution for a biotech facility in Switzerland designed to handle filled bioreactors across GMP areas to produce ten metric tons of antibody per year
  3. The three musketeers of pharmaceutical quality control GMP, GAMP5, and 21CFR11 explained
  4. Microbiological monitoring: Adapting to new rapid methods regulatory demands Dr Wan Li Low from Cherwell takes a look at the shift towards Rapid Microbiology Methods (RMM) and their validation
  5. Endotoxin control in depyrogenation tunnels Understanding the way glassware is depyrogenated and how high concentrations of endotoxin can be used to assess how well depyrogenation tunnels are functioning is key to quality control. Tim Sandle explains

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Analysis

Phillip Godden speaks up about Enzyme Indicator technology

What is the market penetration of the EI technology and why should companies consider the new method for bio-decontamination validation? Phillip Godden, Protak Scientific CEO, answers these questions and comments on the support received by the MHRA
Hi Tech Manufacturing

The three musketeers of pharmaceutical quality control

GMP, GAMP5, and 21CFR11 explained
Hi Tech Manufacturing

The importance of liquid particle counting in public health and safety

Ensuring the purity of water, pharmaceuticals, and food products through precise contamination monitoring
Design & Build

Isopod rapid cleanrooms helping life science start-ups and smaller businesses grow

The Guardtech Group’s quick-assembly pods provide a fast, high-quality cleanroom solution
Design & Build

Introducing the ActiveCount Remote Impactor Kit

An innovative solution for small-space sampling in cleanrooms
Hi Tech Manufacturing

The importance of ultra pure water in critical industries

How advanced tools maintain purity for semiconductors and pharmaceuticals
Design & Build

Biopharma design-build firm ZETA expands with new subsidiary in Kazakhstan

The Austria-based company provides planning and construction of a process system, through the cleanroom design, up to the technical building infrastructure
Subscribe now